NKGen Biotech, Inc. Quarterly Return On Equity in % from Q4 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NKGen Biotech, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q2 2024.
  • NKGen Biotech, Inc. Return On Equity for the quarter ending June 30, 2024 was 158 %, a 36.5% decline year-over-year.
  • NKGen Biotech, Inc. annual Return On Equity for 2023 was 283 %, a 207% increase from 2022.
  • NKGen Biotech, Inc. annual Return On Equity for 2022 was 92.2 %, a 1339% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 158 -90.7 -36.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 192 +60.3 +45.8% Jan 1, 2024 Mar 31, 2024
Q4 2023 283 +191 +207% Oct 1, 2023 Dec 31, 2023
Q3 2023 508 +495 +3802% Jul 1, 2023 Sep 30, 2023
Q2 2023 248 +272 Apr 1, 2023 Jun 30, 2023
Q1 2023 132 +138 Jan 1, 2023 Mar 31, 2023
Q4 2022 92.2 +85.8 +1339% Oct 1, 2022 Dec 31, 2022
Q3 2022 13 Jul 1, 2022 Sep 30, 2022
Q2 2022 -23.5 Apr 1, 2022 Jun 30, 2022
Q1 2022 -5.93 Jan 1, 2022 Mar 31, 2022
Q4 2021 6.4 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.